XYMOGEN Surpasses Seven Million Dollar Month Milestone

XYMOGEN Surpasses Seven Million Dollar Month Milestone

ORLANDO, Fla. -- February 26, 2015 -- Orlando-based health sciences company XYMOGEN has announced it surpassed the Seven Million Dollar Month Revenue Milestone for January-2015. This represents the third consecutive January in which the company surpassed a Million-Dollar Milestone, reaching $5 million and $6 million in 2013 and 2014, respectively.

"This is a very promising start to 2015, and I don't see this dollar mark as a one-time occurrence," said XYMOGEN CEO Brian Blackburn. "With many initiatives in place as we launch 2015, I believe XYMOGEN will eclipse the $8 million mark in the third quarter of this year."

The company's revenues have been steadily increasing since their inception in 2003. Even at a time when few companies are growing, XYMOGEN has seen consistent sales growth for 44 consecutive quarters, and realized over 500 percent growth in the past five years. XYMOGEN's annual sales have skyrocketed from just over $5.2 million in 2004 to more than $68 million by the end of 2014.

"To really put things into perspective, our net sales for this one month were 30 percent larger than our entire first full year in 2004," Blackburn said. "While XYMOGEN has diversified its business model to include Contract Manufacturing and International Sales, the vast majority of growth came from the North American Practitioner-Channel."

XYMOGEN, who began selling their formulas internationally with Canada in 2012, now has product available in more than 16 different countries, across six continents. Blackburn believes the company's international growth is extremely important, as by reaching beyond the United States into international markets, XYMOGEN can achieve their ultimate goal to positively impact the health of people worldwide. "XYMOGEN was founded based upon what we felt were voids in the Practitioner-Channel of the nutracetutical industry," Blackburn said. "In particular, XYMOGEN focused on Exclusive and Patented Ingredients, Evidence-Based Dosing, and a strategy to eliminate the Internet sale of its professional formulas. XYMOGEN's ePedigree program has been highly successful with only 16 of its 230+ formulas available on the Internet as of January 31, 2015."

The company began manufacturing their own formulas when they opened their new, 136,000-square-foot, state-of-the-art manufacturing facility and headquarters in 2012. Since that time, the facility has been GMP (Good Manufacturing Practices) and GMP for Sport registered with NSF International, one of the most respected independent product testing organizations. They also expect to be certified by the Australia Therapeutic Goods Association early in 2015.

To ensure future success, the company continues to improve their manufacturing capabilities and invest in practitioner education, international expansion and security initiatives, such as the aforementioned ePedigree track and trace program. These efforts, according to Blackburn, will allow the company to remain the fastest-growing company in the marketplace and guarantee that XYMOGEN's formulas are the most thoroughly researched and tested that the industry has to offer.

Share This Post:

Instagram

Latest Tweets

Become a XYMOGEN Insider

Join our mailing list.
Interested in receiving special offers, access to exclusive webinars, seminars, up-to-date industry news, and so much more? Sign up for our FREE newsletter and get started today!

BONUS: As a XYMOGEN Insider, you will also get a FREE digital copy of The Rise of Integrative Health & Medicine—The Milestones: 1963–Present by Glenn Sabin and Taylor Walsh.

Privacy Policy

Introduction

We at XYMOGEN, are committed to respecting your online privacy and recognize your need for appropriate protection and management of any personally identifiable information ("Personal Information") you share with us.

XYMOGEN has established this Online Privacy Policy so that you can understand the care with which we intend to treat your Personal Information.

Personal Information means any information that may be used to identify an individual, including, but not limited to, a first and last name, a home or other physical address and an email address or other contact information, whether at work or at home. In general, you can visit XYMOGEN's Web pages without telling us who you are or revealing any Personal Information about yourself.

If you choose to provide us with your Personal Information on the Web, we may transfer that Information within XYMOGEN or to XYMOGEN's third-party service providers, across borders, and from your country or jurisdiction to other countries or jurisdictions around the world.

XYMOGEN strives to comply with all applicable laws around the globe that are designed to protect your privacy. Although legal requirements may vary from country to country, XYMOGEN intends to adhere to the principles set forth in this Online Privacy Policy even if, in connection with the above, we transfer your Personal Information from your country to countries that may not require an "adequate" level of protection for your Personal Information. In other words, our goal is to provide protection for your Personal Information no matter where that Personal Information is collected, transferred, or retained.

Cookies and Other Tracking Technologies

Some of our Web pages utilize "cookies" and other tracking technologies. A "cookie" is a small text file that may be used, for example, to collect information about Web site activity. Some cookies and other technologies may serve to recall Personal Information previously indicated by a Web user. Most browsers allow you to control cookies, including whether or not to accept them and how to remove them. You may set most browsers to notify you if you receive a cookie, or you may choose to block cookies with your browser, but please note that if you choose to erase or block your cookies, you will need to re-enter your original user ID and password to gain access to certain parts of the Web site. Tracking technologies may record information such as Internet domain and host names; Internet protocol (IP) addresses; browser software and operating system types; clickstream patterns; and dates and times that our site is accessed. Our use of cookies and other tracking technologies allows us to improve our Web site and your Web experience. We may also analyze information that does not contain Personal Information for trends and statistics.

To protect your privacy, we have adopted the following principles:

Notice

Choice

Security

Access/Accuracy

Notice

Where XYMOGEN collects Personal Information on the web, we intend to post a purpose statement that explains why Personal Information will be collected and whether we plan to share such Personal Information outside of XYMOGEN or those working on XYMOGEN's behalf. XYMOGEN does not intend to transfer Personal Information without your consent to third parties who are not bound to act on XYMOGEN's behalf unless such transfer is legally required.

Choice

You may choose whether or not to provide Personal Information to XYMOGEN. The notice we intend to provide where XYMOGEN collects Personal Information on the Web should help you to make this choice. If you choose not to provide the Personal Information we request, you can still visit most of XYMOGEN's Web sites, but you may be unable to access certain options, offers, and services that involve our interaction with you.

If you chose to have a relationship with XYMOGEN, such as a contractual or other business relationship or partnership, we will naturally continue to contact you in connection with that business relationship.

Security

Wherever your Personal Information may be held within XYMOGEN or on its behalf, we intend to take reasonable and appropriate steps to protect the Personal Information that you share with us from unauthorized access or disclosure.

Access/Accuracy

To the extent that you do provide us with Personal Information, XYMOGEN wishes to maintain accurate Personal Information. Where we collect Personal Information from you on the Web, our goal is to provide a means of contacting XYMOGEN should you need to update or correct that Information. If for any reason those means are unavailable or inaccessible, you may send updates and corrections about your Personal Information to privacy@XYMOGEN.com and we will make reasonable efforts to incorporate the changes in your Personal Information that we hold as soon as practicable.

Third Party Services

Third parties provide certain services available on XYMOGEN.com on XYMOGEN's behalf. XYMOGEN may provide information, including Personal Information, that XYMOGEN collects on the Web to third-party service providers to help us deliver programs, products, information, and services. Service providers are also an important means by which XYMOGEN maintains its Web site and mailing lists. XYMOGEN will take reasonable steps to ensure that these third-party service providers are obligated to protect Personal Information on XYMOGEN's behalf.

XYMOGEN does not intend to transfer Personal Information without your consent to third parties who are not bound to act on XYMOGEN's behalf unless such transfer is legally required. Similarly, it is against XYMOGEN's policy to sell Personal Information collected online without consent.

Children's Privacy

XYMOGEN.com is not structured to attract children. Accordingly, we do not intend to collect Personal Information from anyone we know to be under 13 years of age.

Commitment

We are committed to privacy and, through our membership in the Online Privacy Alliance, are actively involved in and support current industry initiatives to preserve individual privacy rights on the Internet. Protecting your privacy online is an evolving area, and XYMOGEN's Web sites are constantly evolving to meet these demands.

If you have any comments or questions regarding our Online Privacy Policy, please contact us at info@XYMOGEN.com. While we cannot guarantee privacy perfection, we will address any issue to the best of our abilities as soon as possible.

Your Consent

By using this Web site, you consent to the terms of our Online Privacy Policy and to XYMOGEN's processing of Personal Information for the purposes given above as well as those explained where XYMOGEN collects Personal Information on the Web. Should the Online Privacy Policy change, we intend to take every reasonable step to ensure that these changes are brought to your attention by posting all changes prominently on our web site for a reasonable period of time.